Clinical Trial Update: Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating therapeutic drug monitoring of tocilizumab in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Rheumatoid Arthritis, Tocilizumab | Phase 4 | Status: UNKNOWN